Skip to the content
halfrx
← All providers and medications

Compounded tirzepatide vs Mounjaro (tirzepatide, diabetes label)

Verdict

Mounjaro is the better choice of the two, winning on regulatory and complaint risk and approved product or compounded copy (halfrx score 5.1 against 1.8). Compounded tirzepatide is the one to pick if entry price matters more to you.

Computed from the stored fields, so it moves when a price does. Nothing here is written by hand or by a model.

Which is cheaper, Compounded tirzepatide or Mounjaro (tirzepatide, diabetes label)?

Compounded tirzepatide is $199–$359 a month all-in, the range its sellers here charge, oldest read 2026-09-13; Mounjaro (tirzepatide, diabetes label) is $499, read from its own page on 2026-09-21. Every axis below is computed from stored fields rather than written by hand, so the comparison moves when a price does. They were last checked on 2026-09-13 and 2026-09-21. Flags recorded here: Compounded tirzepatide — not FDA approved, manufacturer lawsuit, supply risk. Mounjaro (tirzepatide, diabetes label) is an FDA-approved product and Compounded tirzepatide is a compounded copy made under the pharmacy-compounding exemption, which is a legal status rather than a quality claim. The published formula scores them 1.8 and 5.1 out of 10, arithmetic over the same stored fields rather than an editor's preference. Cost here is scored on what a patient pays once titrated, never on the entry price, because an introductory rate covers the months before anybody has reached the dose they stay on.

Head to head

Compounded tirzepatide against Mounjaro (tirzepatide, diabetes label), one row per axis, with the side that wins each axis marked.
What decides itCompounded tirzepatide
$199–$359/mo
Mounjaro
$499/mo
Entry priceCompounded tirzepatide is $300/mo cheaper to start — $199 against $499.✓ better here—
Regulatory and complaint riskCompounded tirzepatide: 3 serious flags. Mounjaro (tirzepatide, diabetes label): none.—✓ better here
Approved product or compounded copyMounjaro (tirzepatide, diabetes label) supplies an FDA-approved product; Compounded tirzepatide supplies a compounded preparation, which the FDA does not review for safety, efficacy or quality and which can stop shipping if its pharmacy is enjoined.—✓ better here
Compounded tirzepatide publishes no page halfrx will send you toGo to Mounjaro ↗

What separates these two, price aside

  • They share tirzepatide but not the product's legal status: Mounjaro (tirzepatide, diabetes label) is the FDA-approved product and Compounded tirzepatide a compounded preparation, so they are not the same purchase.
503A/503B compounding pharmacies
Compounded tirzepatide
1.8
$199–$359/mo all-in
checked 2026-09-13 — no maintenance-dose price
Not FDA approvedCompounding legal riskManufacturer lawsuitSupply risk
5.1
$499/mo all-in
verified 2026-09-21
Off-label for weightBoxed warning

Compounded tirzepatide

Pros

  • +Access to tirzepatide, the most effective molecule, at $199–$359/mo against Zepbound's $1,086 list.[1]
  • +Vial dosing allows finer titration than branded pens.[1]

Cons

  • −Not FDA approved — no review of safety, efficacy or manufacturing quality.[1]
  • −Eli Lilly has active lawsuits against compounded tirzepatide sellers, including Henry Meds. A ruling against your provider ends your supply.[2]
  • −The tirzepatide shortage that legally permitted mass compounding has been resolved, so the category now operates on contested legal ground.[2]
  • −Zepbound vials through LillyDirect start at $299/mo — the branded gap is far smaller than it was, which weakens the only argument for compounding.[1]

Mounjaro (tirzepatide, diabetes label)

Pros

  • +Same tirzepatide molecule as Zepbound, the most effective approved weight-loss agent.[4]
  • +On-label and readily covered if you have type 2 diabetes.[4]

Cons

  • −Off-label for weight loss without diabetes — expect insurance denial and prescriber reluctance.[4]
  • −Self-pay is $499 a month at every strength through LillyDirect, with no cheaper starting tier: Zepbound, the same molecule on the weight-loss label, is $299 at 2.5 mg and $449 at 7.5 mg and above through the same pharmacy. For weight loss, Zepbound is the cheaper route to the same molecule.[1]
  • −Weekly injection with the same GI side-effect profile.[4]
Mounjaro side effects →Mounjaro dosage →

Comparisons are computed from the fields on each card, not written by hand or by a model, so they change when the data does. Information only, not medical advice. halfrx may earn a commission from some links, which never changes what a comparison says.

Everything on Compounded tirzepatide

Everything on Mounjaro

The registers and documents behind both sides

Two cards compared on the same checks. These are the registers those checks were run against, and the FDA's own pages where either side is a compounded product.

Compounded tirzepatide against Mounjaro, answered

Is Compounded tirzepatide or Mounjaro better for weight loss?
Only Mounjaro has a trial figure recorded here: 11.9% average weight loss, worked out from the kilograms on its label. Compounded tirzepatide has none on this site — a compounded preparation has no trial of its own, so the two cannot be compared on effect and this page does not pick one on it.
Which is cheaper, Compounded tirzepatide or Mounjaro?
Compounded tirzepatide starts lower, at $199 a month against $499. For Compounded tirzepatide ($199–$359) only a starting price is published, not one for the maintenance dose, so which costs less once titrated cannot be worked out here.
Can you switch between Compounded tirzepatide and Mounjaro?
They are the same molecule, tirzepatide, but Compounded tirzepatide is a compounded preparation and Mounjaro the approved product, so switching changes the product even though the molecule stays the same.
Something on this page wrong? Tell us

Please leave out anything about your own health. How a report is handled: privacy.